Related Experiment Videos
Serum urate and renal function in different forms of hypercalcemia.
1Department of Internal Medicine, University Hospital, Uppsala/Sweden.
Experimental and Clinical Endocrinology
|January 1, 1992
Summary
Serum urate levels are elevated in hypercalcemic cancer patients and those with hyperparathyroidism (HPT). While serum urate correlates with kidney function, it
Area of Science:
- Nephrology
- Endocrinology
- Oncology
Background:
- Investigating the interplay between serum calcium, urate, and kidney function is crucial for understanding metabolic disturbances.
- Hypercalcemia, often seen in cancer and hyperparathyroidism (HPT), can impact renal function and urate metabolism.
Purpose of the Study:
- To examine the relationships between serum calcium, serum urate, and kidney function markers (creatinine, urea).
- To compare these relationships across hypercalcemic cancer patients, HPT subjects, and normocalcemic controls.
Main Methods:
- Serum calcium, urate, creatinine, and urea levels were measured in 100 hypercalcemic cancer patients, 113 HPT subjects, and 106 controls.
- Statistical analyses including correlation and multiple regression were employed to assess relationships between variables.
Main Results:
- Both HPT and cancer groups exhibited elevated serum urate compared to controls.
- Serum urate correlated with serum creatinine in all groups; however, a significant correlation with serum calcium was observed only in HPT subjects.
- Serum creatinine showed a significant correlation with serum calcium exclusively in the HPT group.
- Elevated serum urea in cancer patients was attributed to dehydration or catabolism rather than impaired kidney function.
Conclusions:
- Serum urate is linked to kidney function irrespective of calcium levels.
- Serum urate appears associated with hypercalcemia in HPT but not in cancer patients.
- Kidney function, assessed by creatinine, correlates with serum calcium specifically in HPT.